September 22, 2014 8:36 AM ET

Pharmaceuticals

Company Overview of Optimer Pharmaceuticals, Inc.

Executive Profile

Pedro Lichtinger

President of Optimer Pharmaceuticals and Chief Executive Officer of Optimer Pharmaceuticals, Optimer Pharmaceuticals Canada, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships
60--

Background

Mr. Pedro Lichtinger has been the Chief Executive Officer and President of Asterias Biotherapeutics, Inc. since June 09, 2014. Mr. Lichtinger served as the Chief Executive Officer and President of Optimer Pharmaceuticals, Inc. from May 2010 to February 2013. Mr. Lichtinger served as an Executive of Pfizer, Inc. from 1995 to 2009 and as the President of Pfizer's Global Primary Care Business Unit from 2008 to 2009, Area President, Europe from 2006 to 2008, President, Global ...

Corporate Headquarters

101 Hudson Street
Jersey City, New Jersey 07302

United States

Phone: 201-333-8819
Fax: 201-333-8870

Board Members Memberships

Member of Board of Governors
2009-Present
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Science & Technology Committee
2010-2013
Former Chief Executive Officer, President, Director and Member of New Hire Stock Option Committee
2014-Present
Chief Executive Officer, President and Director

Education

MBA 1978
University of Pennsylvania - The Wharton School
BE
Universidad Nacional Autónoma de México

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Optimer Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.